Palsson, O., Love, T. J., Gunnarsdottir, A. I., Gunnarsson, P. S., Runarsdottir, E. E., Krogh, N. S., & Gudbjornsson, B. (2019). Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible. RMD Open, 5(2), e000984.
Chicago Style (17th ed.) CitationPalsson, Olafur, Thorvardur Jon Love, Anna Ingibjorg Gunnarsdottir, Petur Sigurdur Gunnarsson, Eydis Erla Runarsdottir, Niels Steen Krogh, and Bjorn Gudbjornsson. "Patients with Psoriatic Arthritis Who Are Not Eligible for Randomised Controlled Trials for TNF Inhibitors Have Treatment Response and Drug Survival Similar to Those Who Are Eligible." RMD Open 5, no. 2 (2019): e000984.
MLA (9th ed.) CitationPalsson, Olafur, et al. "Patients with Psoriatic Arthritis Who Are Not Eligible for Randomised Controlled Trials for TNF Inhibitors Have Treatment Response and Drug Survival Similar to Those Who Are Eligible." RMD Open, vol. 5, no. 2, 2019, p. e000984.